Multinational companies and their logos

[rachel]

That's a logo with a Bull and Sun disk. Does it fill you with confidence about its product?

This stuff always reminds me of that scene in the Temple of Doom when they are in cave and the woman suddenly realises the walls are moving.
https://www.msn.com/en-au/health/other/ ... r-BB1jKBof

A Weight Loss Pill More Powerful than Ozempic in Development at Novo Nordisk
12 March 2024

Novo Nordisk, the Danish pharmaceutical titan, recently made headlines with its promising early-stage trial results for amycretin, an experimental weight loss pill.

On March 7, the company announced that amycretin could potentially double the effectiveness of its already popular weight loss drug, Wegovy, setting the stage for a new era in obesity treatment. This news resulted in the company’s stock surging.

Novo Nordisk's CEO, Lars Fruergaard Jørgensen, said that amycretin “could develop into a best-in-class medicine.” The firm is renowned for revolutionizing the weight loss medication market with the FDA-approved Wegovy in 2021, building on the unexpected weight reduction benefits of its diabetes drug, Ozempic.

The success of Wegovy and Ozempic has not only catapulted Novo Nordisk into Europe's top-valued company status, surpassing luxury conglomerate LVMH last year, but also significantly contributed to Denmark's economic growth.

The introduction of amycretin propelled Novo Nordisk's market valuation above that of Tesla, ranking it as the 12th most valuable company globally. Here's a deeper look into what makes amycretin a potential game-changer in weight loss medication.

https://x.com/a_nineties/status/1768528463797842323

have so many unfinished little side digs and projects, might be prudent to recap and regroup. but sticking with news, i've seen the first wegovy pouch on a patient here in germany, now FDA is really opening the market for the lizard juice this is the new normal, folks

[napoleon]

Hans Christian Hagedorn (6 March 1888 – 6 October 1971) was the creator of NPH insulin and the founder of Nordisk Insulinlaboratorium, which is known today as Novo Nordisk.

https://en.wikipedia.org/wiki/Hans_Christian_Hagedorn

In the 1930s he became interested in modifying the absorption rate of insulin. He was aware that contaminating proteins slowed the absorption of insulin into the bloodstream, but these caused irritation and side effects. Thus he searched for a protein that would not cause any irritation. He came upon protamine, a protein isolated from fish sperm. Hagedorn discovered that the addition of protamine to insulin caused the insulin to form microscopic clumps. These clumps took longer to dissolve into the bloodstream. This complex of protamine and insulin is known as NPH (neutral protamine Hagedorn) insulin. It is one of the earliest example of engineering drug delivery.